Preferred Drug List (PDL) and the Preferred Drug List Advisory Committee (PDLAC)

 

The Preferred Drug List Advisory Committee (PDLAC) evaluates evidence-based research reviews created through a multi-state collaborative called the Drug Effectiveness Review Project.  The committee determines whether, based on the evidence, all medications in a certain drug class are therapeutically equivalent or not.  If not, the committee determines which drug(s) are clinically superior within the class. 

 

To learn more about the Office of Pharmacy Services Preferred Drug List (PDL), the Preferred Drug List Advisory Committee (PDLAC), Prior Authorization (PA), or Drug Utilization Review (DUR) please click on the following link:

 

http://uwacadweb.uwyo.edu/PDL

 

**The Preferred Drugs chosen for Wyoming Medicaid are based on Medicaid claims data.  Cost information may be different than the prices at your local pharmacy. For information on the lowest cost alternative at your pharmacy, check with your local pharmacist.